Advertisement

Complete Percutaneous Revascularization in Patients Aged ≥85 Years With Acute Coronary Syndrome and Multivessel Coronary Artery Disease

      Multivessel coronary disease is frequent in older patients who underwent coronary angiography for acute coronary syndrome. Whether a complete revascularization or a culprit-only approach is preferable in these patients is still debated. We included consecutive patients aged ≥85 years, presenting with acute coronary syndrome and showing multivessel coronary disease at coronary angiography. Patients were grouped according to complete (residual SYNTAX score [RSS] 0 to 8) or incomplete (RSS >8) revascularization. Primary end point was the rate of major adverse cardiovascular events (MACEs, the composite of cardiovascular death, re-myocardial infarction [re-MI], clinically driven percutaneous coronary intervention, and rehospitalization because of cardiac disease) at 2 years follow-up. A total of 166 patients met the criteria for enrollment; 108 patients had a final RSS 0 to 8 (complete revascularization) and 58 patients had a final RSS >8 (incomplete revascularization). The rate of MACE was reduced in patients who underwent complete revascularization (35.2% vs 51.7%, p = 0.039, adjusted hazard ratio 0.60, 95% confidence interval 0.37 to 0.98, p = 0.04), a difference mainly driven by a reduction in re-MI (8.3% vs 19.0%, p = 0.045), clinically driven percutaneous coronary intervention (2.8% vs 19.0%, p <0.001), and rehospitalization for cardiac disease (9.3% vs 24.1%, p = 0.009). Other independent predictors of MACE were active malignancy, previous MI, left ventricle ejection fraction <35% (increasing risk of events), and radial access (reducing risk of events). In conclusion, in patients aged ≥85 years, a complete revascularization is associated with a better prognosis, especially in terms of nonfatal events.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Madhavan MV
        • Gersh BJ
        • Alexander KP
        • Granger CB
        • Stone GW.
        Coronary artery disease in patients ≥80 years of age.
        J Am Coll Cardiol. 2018; 71: 2015-2040
        • Knuuti J
        • Wijns W
        • Saraste A
        • Capodanno D
        • Barbato E
        • Funck-Brentano C
        • Prescott E
        • Storey RF
        • Deaton C
        • Cuisset T
        • Agewall S
        • Dickstein K
        • Edvardsen T
        • Escaned J
        • Gersh BJ
        • Svitil P
        • Gilard M
        • Hasdai D
        • Hatala R
        • Mahfoud F
        • Masip J
        • Muneretto C
        • Valgimigli M
        • Achenbach S
        • Bax JJ
        • ESC Scientific Document Group
        2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
        Eur Heart J. 2020; 41: 407-477
        • Neumann FJ
        • Sousa-Uva M
        • Ahlsson A
        • Alfonso F
        • Banning AP
        • Benedetto U
        • Byrne RA
        • Collet JP
        • Falk V
        • Head SJ
        • Jüni P
        • Kastrati A
        • Koller A
        • Kristensen SD
        • Niebauer J
        • Richter DJ
        • Seferovic PM
        • Sibbing D
        • Stefanini GG
        • Windecker S
        • Yadav R
        • Zembala MO
        • ESC Scientific Document Group
        2018 ESC/EACTS Guidelines on myocardial revascularization.
        Eur Heart J. 2019; 40: 87-165
        • Collet JP
        • Thiele H
        • Barbato E
        • Barthélémy O
        • Bauersachs J
        • Bhatt DL
        • Dendale P
        • Dorobantu M
        • Edvardsen T
        • Folliguet T
        • Gale CP
        • Gilard M
        • Jobs A
        • Jüni P
        • Lambrinou E
        • Lewis BS
        • Mehilli J
        • Meliga E
        • Merkely B
        • Mueller C
        • Roffi M
        • Rutten FH
        • Sibbing D
        • Siontis GCM
        • ESC Scientific Document Group
        2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
        Eur Heart J. 2021; 42: 1289-1367
        • Ibanez B
        • James S
        • Agewall S
        • Antunes MJ
        • Bucciarelli-Ducci C
        • Bueno H
        • Caforio ALP
        • Crea F
        • Goudevenos JA
        • Halvorsen S
        • Hindricks G
        • Kastrati A
        • Lenzen MJ
        • Prescott E
        • Roffi M
        • Valgimigli M
        • Varenhorst C
        • Vranckx P
        • Widimský P
        • Scientific Document Group ESC
        ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2017; 39 (2018): 119-177
        • Généreux P
        • Campos CM
        • Farooq V
        • Bourantas CV
        • Mohr FW
        • Colombo A
        • Morel MA
        • Feldman TE
        • Holmes Jr, DR
        • Mack MJ
        • Morice MC
        • Kappetein AP
        • Palmerini T
        • Stone GW
        • Serruys PW.
        Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.
        Am J Cardiol. 2015; 116: 174-186
        • Généreux P
        • Palmerini T
        • Caixeta A
        • Rosner G
        • Green P
        • Dressler O
        • Xu K
        • Parise H
        • Mehran R
        • Serruys PW
        • Stone GW.
        Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.
        J Am Coll Cardiol. 2012; 59: 2165-2174
        • Sianos G
        • Morel MA
        • Kappetein AP
        • Morice MC
        • Colombo A
        • Dawkins K
        • van den Brand M
        • Van Dyck N
        • Russell ME
        • Mohr FW
        • Serruys PW.
        The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
        EuroIntervention. 2005; 1: 219-227
        • Farooq V
        • Serruys PW
        • Bourantas CV
        • Zhang Y
        • Muramatsu T
        • Feldman T
        • Holmes DR
        • Mack M
        • Morice MC
        • Ståhle E
        • Colombo A
        • de Vries T
        • Morel MA
        • Dawkins KD
        • Kappetein AP
        • Mohr FW.
        Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial validation of the residual SYNTAX score.
        Circulation. 2013; 128: 141-151
        • Mehran R
        • Rao SV
        • Bhatt DL
        • Gibson CM
        • Caixeta A
        • Eikelboom J
        • Kaul S
        • Wiviott SD
        • Menon V
        • Nikolsky E
        • Serebruany V
        • Valgimigli M
        • Vranckx P
        • Taggart D
        • Sabik JF
        • Cutlip DE
        • Krucoff MW
        • Ohman EM
        • Steg PG
        • White H.
        Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
        Circulation. 2011; 123: 2736-2747
        • Bach RG
        • Cannon CP
        • Weintraub WS
        • DiBattiste PM
        • Demopoulos LA
        • Anderson HV
        • DeLucca PT
        • Mahoney EM
        • Murphy SA
        • Braunwald E.
        The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes.
        Ann Intern Med. 2004; 141: 186-195
        • Tegn N
        • Abdelnoor M
        • Aaberge L
        • Endresen K
        • Smith P
        • Aakhus S
        • Gjertsen E
        • Dahl-Hofseth O
        • Ranhoff AH
        • Gullestad L
        • Bendz B
        After Eighty study investigators. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
        Lancet. 2016; 387: 1057-1065
        • Savonitto S
        • Cavallini C
        • Petronio AS
        • Murena E
        • Antonicelli R
        • Sacco A
        • Steffenino G
        • Bonechi F
        • Mossuti E
        • Manari A
        • Tolaro S
        • Toso A
        • Daniotti A
        • Piscione F
        • Morici N
        • Cesana BM
        • Jori MC
        • De Servi S.
        Early aggressive versus initially conservative treatment in elderly patients with non–ST-segment elevation acute coronary syndrome: a randomized controlled trial.
        JACC Cardiovasc Interv. 2012; 5: 906-916
        • Galasso G
        • De Servi S
        • Savonitto S
        • Strisciuglio T
        • Piccolo R
        • Morici N
        • Murena E
        • Cavallini C
        • Petronio AS
        • Piscione F.
        Effect of an invasive strategy on outcome in patients ≥ 75 years of age with non-ST-elevation acute coronary syndrome.
        Am J Cardiol. 2015; 115: 576-580
        • Skolnick AH
        • Alexander KP
        • Chen AY
        • Roe MT
        • Pollack Jr, CV
        • Ohman EM
        • Rumsfeld JS
        • Gibler WB
        • Peterson ED
        • Cohen DJ.
        Characteristics, management, and outcomes of 5,557 patients age >or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.
        J Am Coll Cardiol. 2007; 49: 1790-1797
        • Devlin G
        • Gore JM
        • Elliott J
        • Wijesinghe N
        • Eagle KA
        • Avezum A
        • Huang W
        • Brieger D
        • GRACE Investigators
        Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
        Eur Heart J. 2008; 29: 1275-1282
        • Angeli F
        • Verdecchia P
        • Savonitto S
        • Morici N
        • De Servi S
        • Cavallini C.
        Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age.
        Catheter Cardiovasc Interv. 2014; 83: 686-701
        • Mehta SR
        • Wood DA
        • Storey RF
        • Mehran R
        • Bainey KR
        • Nguyen H
        • Meeks B
        • Di Pasquale G
        • López-Sendón J
        • Faxon DP
        • Mauri L
        • Rao SV
        • Feldman L
        • Steg PG
        • Avezum Á
        • Sheth T
        • Pinilla-Echeverri N
        • Moreno R
        • Campo G
        • Wrigley B
        • Kedev S
        • Sutton A
        • Oliver R
        • Rodés-Cabau J
        • Stanković G
        • Welsh R
        • Lavi S
        • Cantor WJ
        • Wang J
        • Nakamya J
        • Bangdiwala SI
        • Cairns JA
        COMPLETE Trial Steering Committee and Investigators. Complete revascularization with multivessel PCI for myocardial infarction.
        N Engl J Med. 2019; 381: 1411-1421
        • Puymirat E
        • Cayla G
        • Simon T
        • Steg PG
        • Montalescot G
        • Durand-Zaleski I
        • le Bras A
        • Gallet R
        • Khalife K
        • Morelle JF
        • Motreff P
        • Lemesle G
        • Dillinger JG
        • Lhermusier T
        • Silvain J
        • Roule V
        • Labèque JN
        • Rangé G
        • Ducrocq G
        • Cottin Y
        • Blanchard D
        • Charles Nelson A
        • De Bruyne B
        • Chatellier G
        Danchin N, FLOWER-MI Study Investigators. Multivessel PCI guided by FFR or angiography for myocardial infarction.
        N Engl J Med. 2021; 385: 297-308
        • Joshi FR
        • Lønborg J
        • Sadjadieh G
        • Helqvist S
        • Holmvang L
        • Sørensen R
        • Jørgensen E
        • Pedersen F
        • Tilsted HH
        • Høfsten D
        • Køber L
        • Kelbaek H
        • Engstrøm T.
        The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: results from the DANAMI-3-PRIMULTI randomized study.
        Catheter Cardiovasc Interv. 2021; 97: E467-E474
        • Gershlick AH
        • Khan JN
        • Kelly DJ
        • Greenwood JP
        • Sasikaran T
        • Curzen N
        • Blackman DJ
        • Dalby M
        • Fairbrother KL
        • Banya W
        • Wang D
        • Flather M
        • Hetherington SL
        • Kelion AD
        • Talwar S
        • Gunning M
        • Hall R
        • Swanton H
        • McCann GP.
        Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.
        J Am Coll Cardiol. 2015; 65: 963-972
        • Wald DS
        • Morris JK
        • Wald NJ
        • Chase AJ
        • Edwards RJ
        • Hughes LO
        • Berry C
        • Oldroyd KG
        • Investigators PRAMI
        Randomized trial of preventive angioplasty in myocardial infarction.
        N Engl J Med. 2013; 369: 1115-1123
        • Smits PC
        • Abdel-Wahab M
        • Neumann FJ
        • Boxma-de Klerk BM
        • Lunde K
        • Schotborgh CE
        • Piroth Z
        • Horak D
        • Wlodarczak A
        • Ong PJ
        • Hambrecht R
        • Angerås O
        • Richardt G
        • Omerovic E
        Compare-Acute Investigators. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction.
        N Engl J Med. 2017; 376: 1234-1244
        • Morici N
        • Alicandro G
        • Ferri LA
        • Piatti L
        • Grosseto D
        • Sganzerla P
        • Tortorella G
        • Ferrario M
        • Crimi G
        • Bossi I
        • Tondi S
        • Petronio AS
        • Mariani M
        • Toso A
        • Ravera A
        • Corrada E
        • Cao D
        • Di Ascenzo L
        • La Vecchia C
        • De Servi S
        • Savonitto S
        Residual SYNTAX score and one-year outcome in elderly patients With acute coronary syndrome.
        CJC Open. 2020; 2: 236-243
        • De La Torre Hernandez JM
        • Gomez Hospital JA
        • Baz JA
        • Brugaletta S
        • Perez de Prado A
        • Linares JA
        • Lopez Palop R
        • Cid B
        • Garcia Camarero T
        • Diego A
        • Gutierrez H
        • Fernandez Diaz JA
        • Sanchis J
        • Alfonso F
        • Blanco R
        • Botas J
        • Navarro Cuartero J
        • Moreu J
        • Bosa F
        • Vegas JM
        • Elizaga J
        • Arrebola AL
        • Hernandez F
        • Salvatella N
        • Monteagudo M
        • Gomez Jaume A
        • Carrillo X
        • Martin Reyes R
        • Lozano F
        • Rumoroso JR
        • Andraka L
        • Dominguez AJ
        Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
        Cardiovasc Revasc Med. 2018; 19: 580-588
        • Agra-Bermejo R
        • Cordero A
        • Veloso PR
        • Álvarez DI
        • Álvarez BÁ
        • Díaz B
        • Rodríguez LA
        • Abou-Jokh C
        • Álvarez BC
        • González-Juanatey JR
        • Acuña JMG.
        Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: real world evidence.
        Rev Cardiovasc Med. 2021; 22: 475-482
        • Siddiqui AJ
        • Omerovic E
        • Holzmann MJ
        • Böhm F.
        Association of coronary angiographic lesions and mortality in patients over 80 years with NSTEMI.
        Open Heart. 2022; 9e001811
        • Harada M
        • Miura T
        • Kobayashi T
        • Kobayashi H
        • Kobayashi M
        • Nakajima H
        • Kimura H
        • Akanuma H
        • Mawatari E
        • Sato T
        • Hotta S
        • Kamiyoshi Y
        • Maruyama T
        • Watanabe N
        • Eisawa T
        • Hashizume N
        • Ebisawa S
        • Miyashita Y
        • Ikeda U
        SHINANO registry investigators. Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: a sub-analysis of the SHINANO registry.
        Int J Cardiol. 2017; 230: 413-419
        • Berezhnoi K
        • Kokov L
        • Vanyukov A.
        Effects of complete revascularization on long-term treatment outcomes in patients with multivessel coronary artery disease over 80 years of age admitted for acute coronary syndrome.
        Cardiovasc Diagn Ther. 2019; 9: 301-309
        • Yazji K
        • Abdul F
        • Elangovan S
        • Ossei-Gerning N
        • Choudhury A
        • Cockburn J
        • Anderson R
        • Mamas M
        • Kinnaird T.
        Comparison of the effects of incomplete revascularizationon 12-month mortality in patients<80 compared with ≥ 80 years who underwent percutaneous coronary intervention.
        Am J Cardiol. 2016; 118: 1164-1170
        • Chen J
        • Xue Q
        • Bai J
        • Gao L
        • Tian JW
        • Li K
        • Xu Q
        • Li YH
        • Wang Y.
        Incomplete revascularization in the drug eluting stent era permits meaningful long-term (12–78 months) outcomes in patients ≥ 75 years with acute coronary syndrome.
        J Geriatr Cardiol. 2012; 9: 336-343
        • Rumiz E
        • Berenguer A
        • Vilar JV
        • Valero E
        • Facila L
        • Cubillos A
        • Sanmiguel D
        • Almela P
        • Morell S.
        Long-term outcomes and predictors of morbi-mortality according to age in stemi patients with multivessel disease: impact of an incomplete revascularization.
        Catheter Cardiovasc Interv. 2018; 92: E512-E517
        • Hasdai D
        • Topol EJ
        • Kilaru R
        • Battler A
        • Harrington RA
        • Vahanian A
        • Ohman EM
        • Granger CB
        • Van de Werf F
        • Simoons ML
        • O'Connor CM
        • Jr Holmes DR
        Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
        Am Heart J. 2003; 145: 73-79
        • Velazquez EJ
        • Francis GS
        • Armstrong PW
        • Aylward PE
        • Diaz R
        • O'Connor CM
        • White HD
        • Henis M
        • Rittenhouse LM
        • Kilaru R
        • van Gilst W
        • Ertl G
        • Maggioni AP
        • Spac J
        • Weaver WD
        • Rouleau JL
        • McMurray JJ
        • Pfeffer MA
        • Califf RM
        • registry VALIANT
        An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
        Eur Heart J. 2004; 25: 1911-1919
        • Kwok CS
        • Bachmann MO
        • Mamas MA
        • Stirling S
        • Shepstone L
        • Myint PK
        • Zaman MJ.
        Effect of age on the prognostic value of left ventricular function in patients with acute coronary syndrome: a prospective registry study.
        Eur Heart J Acute Cardiovasc Care. 2017; 6: 191-198
        • Biscaglia S
        • Guiducci V
        • Santarelli A
        • Amat Santos I
        • Fernandez-Aviles F
        • Lanzilotti V
        • Varbella F
        • Fileti L
        • Moreno R
        • Giannini F
        • Colaiori I
        • Menozzi M
        • Redondo A
        • Ruozzi M
        • Gutiérrez Ibañes E
        • Díez Gil JL
        • Maietti E
        • Biondi Zoccai G
        • Escaned J
        • Tebaldi M
        • Barbato E
        • Dudek D
        • Colombo A
        • Campo G
        Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: rationale and design of the FIRE trial.
        Am Heart J. 2020; 229: 100-109